Global Restructuring Review - Cross-border restructuring and insolvency legal news, features and events

US pharma manufacturer enters Chapter 11 after failed takeover and FDA warnings

By Teodor Teofilov

22 May 2020

US pharma manufacturer enters Chapter 11 after failed takeover and FDA warnings Photo By Pavel Kapysh/Shutterstock

Aiming to seek an in-court sale of its business, international pharma company Akorn and its US subsidiaries have entered Chapter 11 following a failed takeover and multiple actions and warnings from the US’s Federal Drug Administration.